DK163829B - Fremgangsmaade til fremstilling af 2-guanidino-4-(2-(substitueret-amino)-4-imidazolyl)-thiazoler - Google Patents

Fremgangsmaade til fremstilling af 2-guanidino-4-(2-(substitueret-amino)-4-imidazolyl)-thiazoler Download PDF

Info

Publication number
DK163829B
DK163829B DK205883A DK205883A DK163829B DK 163829 B DK163829 B DK 163829B DK 205883 A DK205883 A DK 205883A DK 205883 A DK205883 A DK 205883A DK 163829 B DK163829 B DK 163829B
Authority
DK
Denmark
Prior art keywords
formula
alkyl
amino
substituted
compound
Prior art date
Application number
DK205883A
Other languages
Danish (da)
English (en)
Other versions
DK205883A (da
DK205883D0 (da
Inventor
John Lawrence Lamattina
Christopher Andrew Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK205883D0 publication Critical patent/DK205883D0/da
Publication of DK205883A publication Critical patent/DK205883A/da
Publication of DK163829B publication Critical patent/DK163829B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Lubricants (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
DK205883A 1982-05-10 1983-05-09 Fremgangsmaade til fremstilling af 2-guanidino-4-(2-(substitueret-amino)-4-imidazolyl)-thiazoler DK163829B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/376,486 US4435396A (en) 1982-05-10 1982-05-10 Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor
US37648682 1982-05-10

Publications (3)

Publication Number Publication Date
DK205883D0 DK205883D0 (da) 1983-05-09
DK205883A DK205883A (da) 1983-11-11
DK163829B true DK163829B (da) 1992-04-06

Family

ID=23485203

Family Applications (1)

Application Number Title Priority Date Filing Date
DK205883A DK163829B (da) 1982-05-10 1983-05-09 Fremgangsmaade til fremstilling af 2-guanidino-4-(2-(substitueret-amino)-4-imidazolyl)-thiazoler

Country Status (26)

Country Link
US (1) US4435396A (no)
EP (1) EP0094191B1 (no)
JP (1) JPS58206588A (no)
KR (1) KR860000931B1 (no)
AT (1) ATE33649T1 (no)
AU (2) AU539244B2 (no)
CA (1) CA1201120A (no)
CS (1) CS252461B2 (no)
DD (1) DD209828A5 (no)
DE (1) DE3376322D1 (no)
DK (1) DK163829B (no)
EG (1) EG17029A (no)
ES (1) ES8407045A1 (no)
FI (1) FI78481C (no)
GR (1) GR79279B (no)
GT (1) GT198302123A (no)
HU (2) HU196377B (no)
IE (1) IE55229B1 (no)
IL (1) IL68630A (no)
NO (1) NO159932C (no)
NZ (1) NZ204158A (no)
PL (1) PL141199B1 (no)
PT (1) PT76662B (no)
SU (1) SU1195907A3 (no)
YU (1) YU42857B (no)
ZA (1) ZA833286B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4632993A (en) * 1984-10-11 1986-12-30 Pfizer Inc. Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
WO1986003203A1 (en) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Thienylthiazole derivatives
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents
DE3772301D1 (de) * 1986-08-29 1991-09-26 Pfizer 2-guanidino-4-aryl-thiazole fuer die behandlung von peptischen geschwueren.
DE3750023T2 (de) * 1986-10-29 1994-09-29 Pfizer, Inc., New York, N.Y. Verfahren zur Herstellung von 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)Thiazol und dessen kristallinisches Dihydrochlorid-Trihydrat.
JPH08506353A (ja) * 1993-06-15 1996-07-09 フアイザー・インコーポレイテツド ウシもしくはブタの細菌感染における免疫刺激剤としてのh2−拮抗剤
AP3272A (en) * 2008-09-22 2015-05-31 Cayman Chem Co Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prosaglandin D2 mediated diseases
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519637A (en) 1966-12-06 1970-07-07 Hoffmann La Roche 1-(4-thiazolylmethyl)nitroimidazole derivatives
DE2142585A1 (de) * 1971-08-20 1973-02-22 Schering Ag 2-(5-nitro-2-thiazolyl)-benzimidazole
FR2284601A1 (fr) * 1974-09-10 1976-04-09 Inst Francais Du Petrole Composes guanidino-heterocycliques alkyles, leur preparation et leur utilisation comme additifs pour carburants et lubrifiants
US4220654A (en) 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
US4374843A (en) 1980-10-14 1983-02-22 Pfizer Inc. 2-Guanidino-4-heteroarylthiazoles

Also Published As

Publication number Publication date
DK205883A (da) 1983-11-11
AU539244B2 (en) 1984-09-20
ES522223A0 (es) 1984-08-16
YU99683A (en) 1986-02-28
GT198302123A (es) 1984-10-27
ES8407045A1 (es) 1984-08-16
DE3376322D1 (en) 1988-05-26
FI78481C (fi) 1989-08-10
PL141199B1 (en) 1987-07-31
HU196377B (en) 1988-11-28
NO159932C (no) 1989-02-22
ATE33649T1 (de) 1988-05-15
JPS58206588A (ja) 1983-12-01
DD209828A5 (de) 1984-05-23
CS252461B2 (en) 1987-09-17
GR79279B (no) 1984-10-22
NO831632L (no) 1983-11-11
IE831061L (en) 1983-11-10
FI831595L (fi) 1983-11-11
NZ204158A (en) 1986-05-09
AU3081584A (en) 1984-11-08
US4435396A (en) 1984-03-06
IE55229B1 (en) 1990-07-04
AU566755B2 (en) 1987-10-29
CS318483A2 (en) 1987-02-12
ZA833286B (en) 1984-12-24
EP0094191B1 (en) 1988-04-20
PT76662B (en) 1986-04-16
IL68630A (en) 1987-03-31
KR860000931B1 (ko) 1986-07-19
NO159932B (no) 1988-11-14
IL68630A0 (en) 1983-09-30
FI78481B (fi) 1989-04-28
HU190899B (en) 1986-12-28
AU1436383A (en) 1983-11-17
PL241840A1 (en) 1985-01-16
DK205883D0 (da) 1983-05-09
EP0094191A1 (en) 1983-11-16
YU42857B (en) 1988-12-31
SU1195907A3 (ru) 1985-11-30
KR840004745A (ko) 1984-10-24
PT76662A (en) 1983-06-01
FI831595A0 (fi) 1983-05-09
CA1201120A (en) 1986-02-25
EG17029A (en) 1992-06-30

Similar Documents

Publication Publication Date Title
FI78695C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,2-diaminocyklobuten-3,4-dionderivat.
SU1400508A3 (ru) Способ получени производных арилтиазолов
WO2014165090A1 (en) Compounds for the treatment of tuberculosis
DK163829B (da) Fremgangsmaade til fremstilling af 2-guanidino-4-(2-(substitueret-amino)-4-imidazolyl)-thiazoler
US3843668A (en) Certain 4-substituted amino-2,1,3-benzothiadiozoles
FI75821C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 2-guanidino-4-heteroaryltiazoler.
FI72974C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara imidazolylpyridiner.
JPS63216875A (ja) アリールピペラジニル−アルキレンフェニル複素環式化合物
US3449357A (en) 2-((2,6-substituted)phenoxymethyl)-2-imidazolines
WO2014159938A1 (en) Substituted aminothiazoles for the treatment of tuberculosis
NO770014L (no) Fremgangsm}te til fremstilling av hydroazinderivater.
KR860000103B1 (ko) 3'-치환-5'-(2-아미노-4-피리딜)-1', 2', 4'-트리아졸류의 제조 방법
JPS6157307B2 (no)
US4510313A (en) 2-Guanidino-4-heteroarylthiazoles
FI73990C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva imidazolylpyridiner.
DK148258B (da) Analogifremgangsmaade til fremstilling af et aminoalkylfuranderivat
GB2147899A (en) Chemical intermediates derived from cyclobutene
NZ207257A (en) 2-guanidino-thiazoles
NZ199762A (en) Amino-2,1,3-benzothiadiazole and-benzoxadiazole derivatives and pharmaceutical compositions
NZ207258A (en) Substituted imidazoles

Legal Events

Date Code Title Description
PHB Application deemed withdrawn due to non-payment or other reasons